Esteu veient aquestes cites basades en navegacions anteriors relacionades amb sectors com
Nom | Valor | 1 dia Cap | 7 dia Cap | 14 dia Cap | 30 dia Cap | 90 dia Cap | beta |
---|---|---|---|---|---|---|---|
4basebio | n / a | 0.00% | 0.45% | -5.06% | 0.45% | -8.54% | 0.0 |
4D Pharma | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Abcam | 134 | 0.00% | -3.24% | -2.23% | -14.03% | -9.39% | n / a |
Abzena | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 93.25% | n / a |
Agronomia Limitada | 475 | -3.17% | 2.69% | 2.52% | -15.28% | 57.22% | 0.0 |
Al·lergoteràpia | 268 | 1.75% | 5.45% | -7.20% | -17.14% | -23.68% | -0.1 |
Alliance Pharma | 119 | 0.00% | 0.00% | 0.00% | 0.00% | 5.25% | 0.0 |
Grup de cura dels animals | n / a | 1.35% | 6.10% | 5.61% | 3.20% | -5.83% | 0.0 |
Anpari | n / a | -1.28% | 1.99% | 7.69% | -7.23% | -15.38% | 0.0 |
Grup Aptamer | n / a | -1.92% | -3.77% | 0.00% | -13.56% | -39.29% | 0.0 |
Aqua Bounty Technologies Inc. (Reg S) | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Arecor Therapeutics | n / a | 0.00% | 0.00% | -8.43% | -23.23% | -35.04% | 0.0 |
Argent Biopharma Limited NPV (DI) | n / a | 0.00% | -7.69% | -7.69% | -42.86% | -63.08% | n / a |
AstraZeneca | 123 | -1.27% | 1.06% | -11.13% | -14.54% | -7.44% | 0.0 |
Grup Avacta | 461 | -5.41% | -7.89% | 3.70% | -16.67% | -33.96% | -0.1 |
Participacions de referència | n / a | -2.94% | -4.81% | -5.71% | -23.85% | -33.56% | 0.0 |
Beximco Pharmaceuticals Ltd. GDR (Reg S) | 190 | 0.00% | 0.00% | -5.00% | 0.00% | -1.30% | n / a |
Biodexa Pharmaceuticals | 386 | 0.00% | -21.05% | -31.82% | -80.26% | -90.38% | n / a |
Biofrontera AG (DI) | n / a | 0.00% | 1.75% | 1.75% | 1.75% | -1.69% | n / a |
Bioventix | n / a | 4.08% | 4.08% | 7.59% | -8.11% | -20.31% | 0.0 |
BiVictriX Therapeutics | n / a | 0.00% | 33.33% | 17.65% | -23.08% | -16.67% | n / a |
BTG | n / a | 0.00% | 0.12% | 0.30% | 0.42% | 0.60% | n / a |
C4X Discovery Holdings | n / a | 0.00% | 40.35% | 24.03% | -9.09% | -11.44% | n / a |
Grup de marques Chill | 489 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Cizzle Biotechnology Holdings | n / a | -3.23% | -3.23% | 0.00% | -6.25% | -21.05% | 0.0 |
Cyprotex | n / a | 0.00% | 0.63% | 0.78% | 1.26% | 8.81% | n / a |
Dechra Pharmaceuticals | 121 | 0.00% | 0.16% | 0.26% | 0.68% | 1.90% | n / a |
Deepverge Plc | 427 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Destiny Pharma | 410 | 0.00% | -29.41% | 9.09% | -64.71% | -82.35% | n / a |
Grup Diürn | n / a | 0.00% | 0.00% | 0.00% | 0.55% | 176.46% | n / a |
e-Terapèutica | n / a | 0.00% | -7.93% | -1.91% | -22.08% | -40.00% | n / a |
EastPharma Ltd RDA (Reg S) | n / a | 0.00% | -14.29% | -60.00% | 9.09% | 9.09% | n / a |
Grup de Sanitat Animal ECO | n / a | 0.00% | 1.90% | 0.00% | -8.55% | -14.40% | 0.0 |
Eden Research | n / a | 0.00% | -12.07% | 2.00% | -13.56% | -32.89% | 0.0 |
Ergomed | n / a | 0.00% | 0.15% | 0.30% | 0.90% | 22.14% | n / a |
Faron Pharmaceuticals Oy (DI) | n / a | 7.14% | -7.28% | 0.00% | 13.51% | 0.00% | 0.0 |
Futura Medical | 479 | -1.55% | -9.39% | -12.30% | -11.73% | -72.25% | 0.1 |
Biociències Genflow | n / a | 0.00% | 4.59% | -4.21% | -33.87% | -52.33% | 0.0 |
gènere | 128 | -1.46% | -4.26% | -12.35% | -19.30% | -10.21% | 0.0 |
GSK | 129 | -0.67% | 4.82% | -8.80% | -12.73% | -1.66% | 0.0 |
Gunsynd | 527 | 0.00% | 6.38% | 4.17% | 2.04% | 13.64% | 0.0 |
GW Pharmaceuticals | n / a | 0.00% | -8.13% | -7.72% | -3.35% | 42.30% | n / a |
Haleon | n / a | -0.60% | 4.10% | -3.60% | -2.71% | 1.93% | 0.0 |
Hemogenyx Pharmaceuticals | 340 | 0.88% | 2.22% | -9.57% | -6.12% | -54.24% | 0.0 |
Hikma Pharmaceuticals | 125 | -0.32% | 2.50% | -3.58% | -8.41% | -9.64% | 0.0 |
Grup Horizon Discovery | n / a | 0.00% | 0.00% | -1.34% | -4.90% | 86.36% | n / a |
HUTCHMED (Xina) Limitada | 226 | 2.42% | 7.89% | -10.17% | -7.83% | -9.40% | -0.1 |
Hvivo | n / a | 0.00% | 18.92% | 37.50% | 34.69% | 1.54% | n / a |
Immupharma | 328 | 0.98% | 0.59% | -2.83% | -24.26% | -23.13% | 0.1 |
Indivior | 314 | 0.95% | -0.36% | -6.07% | -8.20% | -27.94% | 0.0 |
Ixic | n / a | 4.65% | 14.29% | 16.13% | -5.26% | -25.00% | 0.0 |
LungLife AI, Inc (DI) | n / a | 233.33% | 233.33% | 233.33% | 140.00% | -61.29% | 0.0 |
Maxcyte Inc (DI / REG S) | 330 | 0.00% | 0.00% | 0.00% | 3.93% | -5.13% | n / a |
Grup Mereo Biopharma | n / a | 0.00% | -10.17% | -22.06% | -18.46% | -42.39% | n / a |
Motiu Bio | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
N4 Pharma | n / a | 0.00% | 0.00% | -11.76% | -21.05% | -44.03% | n / a |
Nuformix | 322 | 0.00% | 12.29% | 20.45% | 76.67% | 152.38% | -0.1 |
Okyo Pharma Limited VAN | 403 | 0.00% | -31.71% | -30.00% | -9.68% | -74.07% | n / a |
Ondine Biomedical Inc. NPV (CDI) | n / a | 0.00% | 0.00% | 0.00% | -9.76% | -15.91% | 0.0 |
OptiBiotix Salut | n / a | 2.78% | 13.85% | 27.59% | -1.33% | 8.82% | 0.0 |
Ovoca Bio (CDI) | n / a | 0.00% | 0.00% | -7.41% | -10.71% | -19.35% | 0.0 |
Oxford Biomedica | 125 | -1.64% | 7.36% | 10.33% | -2.29% | -26.45% | 0.0 |
Oxford Cannabinoid Technologies Holdings | n / a | 0.00% | -43.90% | -36.11% | -66.67% | -73.86% | n / a |
Oxford Nanopore Technologies | n / a | 0.26% | 5.36% | 11.97% | 2.52% | -17.55% | -0.1 |
Pfizer Inc. | n / a | 0.00% | 17.46% | 17.46% | 17.46% | 17.46% | n / a |
OJSC Pharmstandard GDR (Reg S) | n / a | 0.00% | -1.75% | 2.89% | -2.00% | 3.16% | n / a |
Plethora Solutions Holdings | n / a | 0.00% | -11.11% | -11.11% | 9.09% | -33.33% | n / a |
Poolbeg Pharma | n / a | 0.00% | 0.00% | 9.31% | -10.00% | -41.94% | 0.0 |
Ciències del Proteoma | 353 | 5.45% | -3.65% | -28.57% | -27.68% | -32.56% | 0.1 |
Salut PureTech | n / a | 0.82% | 19.81% | -11.10% | -7.91% | -13.10% | -0.1 |
Quantum Pharma | n / a | 0.00% | 2.74% | 2.43% | 2.74% | 52.49% | n / a |
Redx Pharma | 278 | 0.00% | 46.34% | 36.36% | -18.92% | -25.00% | n / a |
Grup ReNeuron | 394 | 0.00% | -2.96% | -2.96% | -2.96% | -2.96% | n / a |
Sareum Holdings | 594 | -5.41% | 0.00% | 32.08% | 40.00% | -20.45% | -0.2 |
Scancell Holdings | n / a | 5.00% | 28.83% | 28.83% | 23.53% | 4.48% | -0.3 |
Escut Terapèutic | n / a | -11.32% | -16.07% | -16.07% | -22.95% | 0.00% | 0.0 |
Shire Plc | n / a | 0.00% | 2.63% | 4.36% | 3.42% | 6.88% | n / a |
Terapèutica del silenci | 177 | 0.00% | -1.65% | -0.93% | 5.94% | -9.17% | n / a |
Sinclair Pharma | n / a | 0.00% | 0.00% | 0.32% | 0.47% | 45.21% | n / a |
SkinBioTherapeutics | n / a | 6.25% | 9.68% | -15.00% | -12.37% | 25.93% | -0.1 |
Skyepharma | n / a | 0.00% | -1.94% | -4.47% | -6.39% | 17.35% | n / a |
Terapèutica Solvonis | n / a | -7.69% | -27.27% | -23.81% | -27.27% | -35.14% | 0.0 |
Font BioScience | n / a | 0.00% | -4.11% | -1.41% | -1.41% | 2.19% | n / a |
Summit Therapeutics | n / a | 0.00% | -2.38% | -12.77% | -2.38% | -6.82% | n / a |
Synairgen | 510 | 0.00% | -0.11% | -5.00% | -52.44% | -49.93% | n / a |
Taihua | n / a | 0.00% | -30.00% | 59.09% | -46.15% | -72.00% | n / a |
Theracryf | 304 | 0.00% | 0.00% | 0.00% | 0.00% | -74.29% | 0.0 |
Tiziana Ciències de la vida | n / a | 0.00% | 11.43% | 12.50% | 7.34% | -7.87% | n / a |
Valirx | 435 | 0.00% | -4.76% | 11.11% | -16.67% | -37.50% | 0.0 |
Grup Vectura | 139 | 0.00% | 0.12% | -0.12% | 0.00% | 6.74% | n / a |
Verici DX | 429 | -11.76% | -22.52% | -20.21% | -25.00% | -55.88% | 0.0 |
Vernalis plc | n / a | 0.00% | 0.49% | 0.33% | 0.82% | -4.19% | n / a |
Verona Pharma | n / a | 0.00% | 4.76% | 4.76% | -15.38% | -24.14% | n / a |
Verseon Corporation (DI / REG S) | n / a | 0.00% | 96.72% | 73.91% | -48.94% | -67.74% | n / a |
Verseon Corporation (Reg S Cat 3) | n / a | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | n / a |
Salut de Yourgene | n / a | 0.00% | 0.98% | 0.98% | 5.10% | 139.53% | n / a |